BRIEF-J&J Reports Positive Survival And Outcomes With Impella In Hrpci

3

Nov 1 (Reuters) – Johnson & Johnson: * J&J – REPORTS POSITIVE SURVIVAL AND OUTCOMES WITH IMPELLA IN HRPCI * J&J – REGISTRY DATA SHOW LOWER MORTALITY WITH IMPELLA IN HRPCI THAN CHIP-BCIS3 Source text:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)